Author:
Albitar M,Johnson M,Do K A,Day A,Jilani I,Pierce S,Estey E,Kantarjian H,Keating M,Verstovsek S,O'Brien S,Giles F J
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference42 articles.
1. Cresswell P, Springer T, Strominger JL, Turner MJ, Grey HM, Kubo RT . Immunological identity of the small subunit of HL-A antigens and beta2-microglobulinand its turnover on the cell membrane. Proc Natl Acad Sci USA 1974; 71: 2123–2127.
2. Bataille R, Durie BG, Grenier J . Serum beta2 microglobulin and survival duration in multiple myeloma: a simple reliable marker for staging. Br J Haematol 1983; 55: 439–447.
3. Kantarjian HM, Smith T, Estey E, Polvzos A, O’Brien S, Pierce S et al. Prognostic significance of elevated serum beta 2-microglobulin levels in adult acute lymphocytic leukemia. Am J Med 1992; 93: 599–604.
4. Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB et al. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease. Cancer 2002; 95: 2534–25388.
5. Rodriguez J, Cortes J, Talpaz M, O’Brien S, Smith T, Rios MB et al. Serum beta-2 microglobulin levels are a significant prognostic factor in Philadelphia chromosome-positive chronic myelogenous leukemia. Clin Cancer Res 2000; 6: 147–152.
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献